| 2022-04-07 | Lee Yuchun | Director | Sale+OE | 2,727 | $272.89 | $744,164.40 | -17.1% | → |
| 2022-04-05 | Lee Yuchun | Director | Sale+OE | 4,000 | $270.11 | $1,080,423.57 | -13.5% | → |
| 2022-04-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 3,725 | $274.10 | $1,021,004.50 | -2.7% | → |
| 2022-04-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 2,582 | $264.76 | $683,601.63 | -1.1% | → |
| 2022-03-31 | MCGLYNN MARGARET G | Director | Sale+OE | 5,000 | $262.27 | $1,311,345.89 | -37.6% | → |
| 2022-03-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2,833 | $250.11 | $708,572.06 | -2.9% | → |
| 2022-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3,171 | $250.15 | $793,218.35 | -3.3% | → |
| 2022-03-17 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2,122 | $250.06 | $530,627.32 | -4.2% | → |
| 2022-02-25 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 7,572 | $230.98 | $1,748,989.52 | -4.7% | → |
| 2022-02-25 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 325 | $230.95 | $75,058.08 | -0.1% | → |
| 2022-02-18 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4,312 | $230.97 | $995,949.18 | -1.7% | → |
| 2022-02-18 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 519 | $231.00 | $119,888.58 | -0.2% | → |
| 2022-02-14 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 2,444 | $232.02 | $567,056.88 | -4.1% | → |
| 2022-02-11 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 841 | $233.92 | $196,726.72 | -1.4% | → |